Leaflet CINKONA 300mg tablets


Indicated for: constipation

Route of administration: oral

Substance: quinine sulfate (antimalarial)

ATC: P01BC01 (Antiparasitic products, insecticides and repellents | Antimalarials | Methanolquinolines)

Quinine sulfate is used for the treatment of uncomplicated malaria and other conditions such as nocturnal leg cramps. It works by inhibiting the growth and replication of the malaria parasite within host cells.

The medication is taken orally, as directed by a doctor, usually two or three times daily. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as nausea, diarrhea, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, and dizziness. In rare cases, severe reactions such as cardiac arrhythmias or allergic reactions may occur. Patients should be informed of these risks before use.

General data about CINKONA 300mg

  • Substance: quinine sulfate
  • Date of last drug list: 01-06-2016
  • Commercial code: W56736001
  • Concentration: 300mg
  • Pharmaceutical form: tablets
  • Quantity: 100
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for quinine sulfate

Concentrations available for quinine sulfate

  • 300mg
  • 300mg/ml